Comparison of serum and urinary nephrin levels between normal pregnancies and severe preeclampsia

Kerjaschki, 2001, Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis, Journal of Clinical Investigation, 108, 1583, 10.1172/JCI200114629

Nakamura, 2000, Urinary excretion of podocytes in patients with diabetic nephropathy, Nephrology, Dialysis, Transplantation, 15, 1379, 10.1093/ndt/15.9.1379

Nakamura, 2000, Urinary podocytes for the assessment of disease activity in lupus nephritis, American Journal of the Medical Sciences, 320, 112, 10.1097/00000441-200008000-00009

Pagtalunan, 1997, Podocyte loss and progressive glomerular injury in type II diabetes, Journal of Clinical Investigation, 99, 342, 10.1172/JCI119163

Kestila, 1998, Positionally cloned gene for a novel glomerular protein–nephrin–is mutated in congenital nephrotic syndrome, Molecular Cell, 1, 575, 10.1016/S1097-2765(00)80057-X

Lenkkeri, 1999, Structure of the gene for congenital nephrotic syndrome of the Finnish type (NPHS1) and characterization of mutations, American Journal of Human Genetics, 64, 51, 10.1086/302182

Patrakka, 2007, Nephrin—a unique structural and signaling protein of the kidney filter, Trends in Molecular Medicine, 13, 396, 10.1016/j.molmed.2007.06.006

Redman, 2005, Latest advances in understanding preeclampsia, Science, 308, 1592, 10.1126/science.1111726

Garovic, 2007, Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia, Nephrology, Dialysis, Transplantation, 22, 1136, 10.1093/ndt/gfl711

Collino, 2008, Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells, American Journal of Physiology: Renal Physiology, 294, F1185, 10.1152/ajprenal.00442.2007

Son, 2011, Urinary excretion of nephrin in patients with severe preeclampsia. Urinary nephrin in preeclampsia, Hypertension in Pregnancy, 30, 408, 10.3109/10641955.2010.507841

Levine, 2004, Circulating angiogenic factors and the risk of preeclampsia, New England Journal of Medicine, 350, 672, 10.1056/NEJMoa031884

Maynard, 2003, Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia, Journal of Clinical Investigation, 111, 649, 10.1172/JCI17189

Sugimoto, 2003, Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria, Journal of Biological Chemistry, 278, 12605, 10.1074/jbc.C300012200

Karumanchi, 2005, Preeclampsia: a renal perspective, Kidney International, 67, 2101, 10.1111/j.1523-1755.2005.00316.x

Garovic, 2007, Urinary podocyte excretion as a marker for preeclampsia, American Journal of Obstetrics and Gynecology, 196, e3201, 10.1016/j.ajog.2007.02.007

Aita, 2009, Acute and transient podocyte loss and proteinuria in preeclampsia, Nephron: Clinical Practice, 112, c65, 10.1159/000213083

Wang, 2012, Increased urinary excretion of nephrin, podocalyxin, and betaig-h3 in women with preeclampsia, American Journal of Physiology: Renal Physiology, 302, F1084, 10.1152/ajprenal.00597.2011

Pisitkun, 2004, Identification and proteomic profiling of exosomes in human urine, Proceedings of the National Academy of Sciences of the United States of America, 101, 13368, 10.1073/pnas.0403453101

van Balkom, 2011, Exosomes and the kidney: prospects for diagnosis and therapy of renal diseases, Kidney International, 80, 1138, 10.1038/ki.2011.292

Musante, 2012, Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment, PLoS ONE, 7, e37279, 10.1371/journal.pone.0037279

Astrom, 2006, Nephrin in human lymphoid tissues, Cellular and Molecular Life Sciences, 63, 498, 10.1007/s00018-005-5498-0

Palmen, 2001, Nephrin is expressed in the pancreatic beta cells, Diabetologia, 44, 1274, 10.1007/s001250100641

Zanone, 2005, Expression of nephrin by human pancreatic islet endothelial cells, Diabetologia, 48, 1789, 10.1007/s00125-005-1865-5

Kuusniemi, 2004, Tissue expression of nephrin in human and pig, Pediatric Research, 55, 774, 10.1203/01.PDR.0000117842.10241.2C

Aggarwal, 2006, Low urinary placental growth factor is a marker of pre-eclampsia, Kidney International, 69, 621, 10.1038/sj.ki.5000075

Buhimschi, 2010, The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio, BJOG, 117, 321, 10.1111/j.1471-0528.2009.02434.x

Buhimschi, 2005, Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia, American Journal of Obstetrics and Gynecology, 192, 734, 10.1016/j.ajog.2004.12.052

Aggarwal, 2008, A prospective comparison of random urine protein-creatinine ratio vs 24-hour urine protein in women with preeclampsia, The Medscape Journal of Medicine, 10, 98

Durnwald, 2003, A prospective comparison of total protein/creatinine ratio versus 24-hour urine protein in women with suspected preeclampsia, American Journal of Obstetrics and Gynecology, 189, 848, 10.1067/S0002-9378(03)00849-4

Papanna, 2008, Protein/creatinine ratio in preeclampsia: a systematic review, Obstetrics and Gynecology, 112, 135, 10.1097/AOG.0b013e3181778cfc

Hara, 1998, Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis, American Journal of Nephrology, 18, 35, 10.1159/000013302

Petermann, 2007, Podocyte damage resulting in podocyturia: a potential diagnostic marker to assess glomerular disease activity, Nephron: Clinical Practice, 106, c61, 10.1159/000101799

Yu, 2005, Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria, Journal of the American Society of Nephrology, 16, 1733, 10.1681/ASN.2005020159